Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
10 Health Care Stocks Whale Activity In Today's Session
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Merck Declares $0.77 Dividend
UnitedHealth Group Analyst Ratings
Viiv's Dovato as Effective as Gilead' Biktarvy for HIV but With Less Weight Gain
Election Watch: Will Conservatives and Liberals Move the Meter With Their Stock Picks?
Decoding Thermo Fisher Scientific's Options Activity: What's the Big Picture?
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Notable Earnings Before Wednesday's Open
Amgen, Garmin Among Relative Market Leaders Poised to Outperform in Coming Months: BTIG
What the Options Market Tells Us About UnitedHealth Group
Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance
Market Whales and Their Recent Bets on LLY Options
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Ahead of Big Tech Earnings
Merck RSV Therapy Succeeds in Infants in Challenge to Sanofi, Astra
Danaher Gains as Biotech and Diagnostics Drive Q2 Beat
AbbVie Says Canada's Drug Agency Has Issued Its First-Ever Time-limited Reimbursement Recommendation For EPKINLY (Epcoritamab)
Danaher Beats Q2 Top and Bottom Line Estimates